Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)

Overview of attention for article published in OncoTargets and therapy, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Preoperative blood counts predict overall survival in patients undergoing surgical removal of brain metastasis

Article in World Neurosurgery (April 2024)

Development and adaptations of the Graded Prognostic Assessment (GPA) scale: a systematic review

Article in Clinical & Experimental Metastasis (October 2023)

Prognostic value of cranial radiotherapy and optimal timing stratified by lung-molGPA for NSCLC patients with brain metastases

Article in Journal of Neuro-Oncology (August 2023)